PF-06826647
|
|
|
- CAS號:
- 2127109-84-4
- 英文名:
- Ropsacitinib
- 英文別名:
- Tyk2-IN-8;PF6826647;PF 6826647;PF-6826647;PF-06826647;Ropsacitinib;PF-06826647( Tyk2-IN-8);Ropsacitinib (PF-06826647;Cyclobutaneacetonitrile, 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]-, trans-;cis-3-(Cyanomethyl)-3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}cyclobutanecarbonitrile
- 中文名:
- PF-06826647
- 中文別名:
- 化合物 T13237L;化合物ROPSACITINIB;PF-06826647(PF-06826647);反式-3-(氰基甲基)-3-(4-(6-(1-甲基-1H-吡唑-4-基)吡唑并[1,5-A]吡嗪-4-基)-1H-吡唑-1-基)環(huán)丁烷腈;(1R,3R)-3-(氰甲基)-3-(4-(6-(1-甲基-1H-吡唑-4-基)吡唑[1,5-A]吡嗪-4-基)-1H-吡唑-1-基)環(huán)丁腈
- CBNumber:
- CB04923831
- 分子式:
- C20H17N9
- 分子量:
- 383.41
- MOL File:
- 2127109-84-4.mol
|
|
|
PF-06826647化學(xué)性質(zhì)
-
密度:
-
1.46±0.1 g/cm3(Predicted)
-
|
-
儲存條件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO: 16.67 mg/mL (43.48 mM)
-
|
-
酸度系數(shù)(pKa):
-
0.98±0.19(Predicted)
-
|
PF-06826647性質(zhì)、用途與生產(chǎn)工藝
PF-06826647 (Tyk2-IN-8, compound 10) 是一種選擇性的 tyrosine kinase 2 (TYK2) 的口服抑制劑，IC50值為17 nM，可與TYK2催化活性JH1結(jié)構(gòu)域結(jié)合。PF-06826647 (Tyk2-IN-8, compound 10) 也可抑制 JAK1 和 JAK2，對應(yīng)的IC50值分別為383 nM和74 nM。PF-06826647 (Tyk2-IN-8, compound 10) 可用于治療牛皮癬(PSO)。
| Target | Value |
TYK2
(Cell-free assay)
|
17 nM
|
JAK2
(Cell-free assay)
|
74 nM
|
JAK1
(Cell-free assay)
|
383 nM
|
PF-06826647
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
|---|
| 2024/11/08 | S9676 | PF-06826647
PF-06826647 | 2127109-84-4 | 5mg | 4590元 |
| 2024/11/08 | S9676 | Ropsacitinib (PF-06826647) | 2127109-84-4 | 10mM (1mL in DMSO) | 5487.3元 |
2127109-84-4, PF-06826647 相關(guān)搜索:
- 化工試劑
- 醫(yī)藥原料藥
- 抑制劑
- 化合物ROPSACITINIB
- 反式-3-(氰基甲基)-3-(4-(6-(1-甲基-1H-吡唑-4-基)吡唑并[1,5-A]吡嗪-4-基)-1H-吡唑-1-基)環(huán)丁烷腈
- 化合物 T13237L
- (1R,3R)-3-(氰甲基)-3-(4-(6-(1-甲基-1H-吡唑-4-基)吡唑[1,5-A]吡嗪-4-基)-1H-吡唑-1-基)環(huán)丁腈
- PF-06826647(PF-06826647)
- 2127109-84-4
- PF-6826647
- PF6826647
- PF 6826647
- cis-3-(Cyanomethyl)-3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}cyclobutanecarbonitrile
- Ropsacitinib
- trans-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutanecarbonitrile
- Ropsacitinib (PF-06826647
- PF-06826647( Tyk2-IN-8)
- Cyclobutaneacetonitrile, 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]-, trans-
- Tyk2-IN-8
- PF-06826647
- (1r,3r)-3-(cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutanecarbonitrile